Back to Search Start Over

Intermediate-dose cytarabine or standard-dose cytarabine plus single-dose anthracycline as post-remission therapy in older patients with acute myeloid leukemia: impact on health care resource consumption and outcomes.

Authors :
Galtier J
Alric C
Bérard E
Leguay T
Tavitian S
Bidet A
Delabesse E
Rieu JB
Vial JP
Vergez F
Lechevalier N
Luquet I
Klein E
de Grande AC
Sarry A
Pigneux A
Récher C
Bertoli S
Dumas PY
Source :
Blood cancer journal [Blood Cancer J] 2021 Nov 13; Vol. 11 (11), pp. 180. Date of Electronic Publication: 2021 Nov 13.
Publication Year :
2021

Details

Language :
English
ISSN :
2044-5385
Volume :
11
Issue :
11
Database :
MEDLINE
Journal :
Blood cancer journal
Publication Type :
Editorial & Opinion
Accession number :
34775463
Full Text :
https://doi.org/10.1038/s41408-021-00551-y